Prismaflex HF20 for continuous renal replacement therapy in critically ill children

Artificial Organs

Volumn 35, Issue 12, 2011, Pages 1194-1194

  Santiago, Maria Jose ^a   López Herce, Jesús ^a  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CRITICALLY ILLS; RENAL REPLACEMENT THERAPIES;

ALBUMIN; CREATININE; ELECTROLYTE; HEPARIN; UREA;

ACUTE KIDNEY FAILURE; BLOOD CLOTTING DISORDER; BODY SURFACE; CHILDHOOD DISEASE; CHRONIC KIDNEY FAILURE; CLINICAL PROTOCOL; CONTINUOUS RENAL REPLACEMENT THERAPY; CREATININE BLOOD LEVEL; CRITICALLY ILL PATIENT; EXTRACORPOREAL OXYGENATION; FILTER; HEART SURGERY; HEMOFILTRATION; HUMAN; KIDNEY BLOOD FLOW; LETTER; MULTIPLE ORGAN FAILURE; PRESCRIPTION; PRIORITY JOURNAL; SURVIVAL; UREA BLOOD LEVEL;

EID: 83855162820     PISSN: 0160564X     EISSN: 15251594     Source Type: Journal    
DOI: 10.1111/j.1525-1594.2011.01367.x     Document Type: Letter

References (5)

1. Santiago MJ, López-Herce J, Urbano J, etal. Clinical course and mortality risk factors in critically ill children requiring continuous renal replacement therapy. Intensive Care Med 2010;36:843-9.
2. Rödl S, Marschitz I, Mache CHJ, etal. One-year safe use of the Prismaflex HF20 disposable set in infants in 220 renal replacement treatment sessions. Intensive Care Med 2011;37:884-5.
3. Santiago MJ, Sánchez A, López-Herce J, etal. The use of continuous renal replacement therapy in series with extracorporeal membrane oxygenation. Kidney Int 2009;76:1289-92.
4. Del Castillo J, López-Herce J, Cidoncha E, etal. Circuit life span in critically ill children on continuous renal replacement treatment: a prospective observational evaluation study. Crit Care 2008;12:R93.
5. Santiago MJ, López-Herce J, Urbano J, etal. Complications of continuous renal replacement therapy in critically ill children: a prospective observational evaluation study. Crit Care 2009;13:R184.